ビリルビン血液検査の世界市場2020-2024

◆英語タイトル:Global Bilirubin Blood Test Market 2020-2024
◆商品コード:TNV20FB046
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年1月14日
◆ページ数:100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

「ビリルビン血液検査の世界市場2020-2024」は、ビリルビン血液検査について市場概要、市場規模、種類別(乳児、大人)分析、顧客状況、地域状況、市場の要因・課題、市場トレンド、企業状況、企業分析などを総合的にまとめて調査・分析したものです。
・エグゼクティブサマリー
・レポート範囲
・市場概要
・市場規模
・ファイブフォース分析
・ビリルビン血液検査の世界市場:種類別(乳児、大人)
・顧客状況
・地域状況
・決定フレームワーク
・市場の要因・課題
・市場トレンド
・企業状況
・企業分析
【レポートの概要】

Global Bilirubin Blood Test Market 2020-2024
Technavio has been monitoring the global bilirubin blood test market and it is poised to grow by USD 562.5 mn during 2020-2024, progressing at a CAGR of 8% during the forecast period. Our reports on bilirubin blood test market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of jaundice and liver diseases. In addition, increasing demand for non-invasive procedures is anticipated to boost the growth of the bilirubin blood test market as well.

Market Segmentation

Technavio’s global bilirubin blood test market is segmented as below:
Type
• Infants
• Adults

Geographic segmentation
• Asia
• Europe
• North America
• ROW

Key Trends for bilirubin blood test market growth
This study identifies increasing demand for non-invasive procedures as the prime reasons driving the bilirubin blood test market growth during the next few years.

Prominent vendors in bilirubin blood test market
We provide a detailed analysis of around 25 vendors operating in the bilirubin blood test market, including some of the vendors such as Abbott Laboratories, Danaher Corp., Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd., Koninklijke Philips NV, Merck KGaA, Randox Laboratories Ltd., Reichert Inc., Siemens Healthineers AG and Thermo Fisher Scientific Inc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit -https://www.technavio.com/report/global-bilirubin-blood-test-market-2020-2024

About Technavio
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Value chain analysis
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market outlook
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY TYPE
• Market segmentation by type
• Comparison by type
• Infants – Market size and forecast 2019-2024
• Adults – Market size and forecast 2019-2024
• Market opportunity by type
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
• Growing number of strategic alliances
• Increasing demand for non-invasive procedures
• Government initiatives and funding for bilirubin testing
PART 11: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 12: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott Laboratories
• Danaher Corp.
• Drägerwerk AG & Co. KGaA
• F. Hoffmann-La Roche Ltd.
• Koninklijke Philips NV
• Merck KGaA
• Randox Laboratories Ltd.
• Reichert Inc.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
PART 13: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 14: EXPLORE TECHNAVIO


Exhibit 01: Global healthcare supplies market
Exhibit 02: Segments of global healthcare supplies market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Product overview
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Type – Market share 2019-2024 (%)
Exhibit 19: Comparison by type
Exhibit 20: Infants – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Infants – Year-over-year growth 2020-2024 (%)
Exhibit 22: Adults – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Adults – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by type
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America – Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Product launch details
Exhibit 39: Number of preterm births/LBW infants per 100 live births, 2014
Exhibit 40: Product recalls: Overview
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Business strategies
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Abbott Laboratories – Vendor overview
Exhibit 49: Abbott Laboratories – Business segments
Exhibit 50: Abbott Laboratories – Organizational developments
Exhibit 51: Abbott Laboratories – Geographic focus
Exhibit 52: Abbott Laboratories – Segment focus
Exhibit 53: Abbott Laboratories – Key offerings
Exhibit 54: Abbott Laboratories – Key customers
Exhibit 55: Danaher Corp. – Vendor overview
Exhibit 56: Danaher Corp. – Business segments
Exhibit 57: Danaher Corp. – Organizational developments
Exhibit 58: Danaher Corp. – Geographic focus
Exhibit 59: Danaher Corp. – Segment focus
Exhibit 60: Danaher Corp. – Key offerings
Exhibit 61: Danaher Corp. – Key customers
Exhibit 62: Drägerwerk AG & Co. KGaA – Vendor overview
Exhibit 63: Drägerwerk AG & Co. KGaA – Organizational developments
Exhibit 64: Drägerwerk AG & Co. KGaA – Geographic focus
Exhibit 65: Drägerwerk AG & Co. KGaA – Key offerings
Exhibit 66: Drägerwerk AG & Co. KGaA – Key customers
Exhibit 67: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 68: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 69: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 70: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 71: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 72: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 73: F. Hoffmann-La Roche Ltd. – Key customers
Exhibit 74: Koninklijke Philips NV – Vendor overview
Exhibit 75: Koninklijke Philips NV – Business segments
Exhibit 76: Koninklijke Philips NV – Organizational developments
Exhibit 77: Koninklijke Philips NV – Geographic focus
Exhibit 78: Koninklijke Philips NV – Segment focus
Exhibit 79: Koninklijke Philips NV – Key offerings
Exhibit 80: Koninklijke Philips NV – Key customers
Exhibit 81: Merck KGaA – Vendor overview
Exhibit 82: Merck KGaA – Business segments
Exhibit 83: Merck KGaA – Organizational developments
Exhibit 84: Merck KGaA – Geographic focus
Exhibit 85: Merck KGaA – Segment focus
Exhibit 86: Merck KGaA – Key offerings
Exhibit 87: Merck KGaA – Key customers
Exhibit 88: Randox Laboratories Ltd. – Vendor overview
Exhibit 89: Randox Laboratories Ltd. – Business segments
Exhibit 90: Randox Laboratories Ltd. – Key offerings
Exhibit 91: Randox Laboratories Ltd. – Key customers
Exhibit 92: Reichert Inc. – Vendor overview
Exhibit 93: Reichert Inc. – Business segments
Exhibit 94: Reichert Inc. – Key offerings
Exhibit 95: Reichert Inc. – Key customers
Exhibit 96: Siemens Healthineers AG – Vendor overview
Exhibit 97: Siemens Healthineers AG – Business segments
Exhibit 98: Siemens Healthineers AG – Organizational developments
Exhibit 99: Siemens Healthineers AG – Geographic focus
Exhibit 100: Siemens Healthineers AG – Segment focus
Exhibit 101: Siemens Healthineers AG – Key offerings
Exhibit 102: Siemens Healthineers AG – Key customers
Exhibit 103: Thermo Fisher Scientific Inc. – Vendor overview
Exhibit 104: Thermo Fisher Scientific Inc. – Business segments
Exhibit 105: Thermo Fisher Scientific Inc. – Organizational developments
Exhibit 106: Thermo Fisher Scientific Inc. – Geographic focus
Exhibit 107: Thermo Fisher Scientific Inc. – Segment focus
Exhibit 108: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 109: Thermo Fisher Scientific Inc. – Key customers
Exhibit 110: Validation techniques employed for market sizing
Exhibit 111: Definition of market positioning of vendors



【掲載企業】

Abbott Laboratories
Danaher Corp.
Drägerwerk AG & Co. KGaA

F. Hoffmann-La Roche Ltd.

Koninklijke Philips NV

Merck KGaA

Randox Laboratories Ltd.

Reichert Inc.

Siemens Healthineers AG

Thermo Fisher Scientific Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ビリルビン血液検査の世界市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆